RAPID framework for improved access to precision oncology for lethal disease: Results from a modified multi-round delphi study
{{output}}
Introduction: Predictive oncology, germline technologies, and adaptive seamless trials are promising advances in the treatment of lethal cancers. Yet, access to these therapies is stymied by costly research, regulatory barriers, ... ...
